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Background: Self-harm in adolescents is common and repetition frequent. Evidence for effective interven-
tions to reduce self-harm is limited. Long term follow-up of existing studies is rare.
Methods: Extended follow up, from 18 to at least 36-months, of the SHIFT trial: a pragmatic, multi-centre,
individually-randomised, controlled trial involving young people (1117) who had self-harmed at least
twice and presented to Child & Adolescent Mental Health Services (CAMHS). SHIFT evaluated manualised
family therapy (FT) versus treatment as usual (TAU) in reducing repetition of self-harm leading to hospital
attendance 18 months post-randomisation.
We obtained ONS mortality data, adult mental health data, and further details of hospital attendance from
routine Hospital Episode Statistics (HES) data plus researcher follow-up. We assessed longer-term differen-
ces in outcome using multivariable Cox Proportional Hazards regression analysis, and assessed all-cause
mortality and morbidity relating to hospital attendances for reasons other than self-harm.
Study registration: ISRCTN 59793150
Outcomes: The original sample of 832 were randomised between April 2010 and December 2013. Extended
follow-up continued until February 2017 for a median 55¢4 months (range 082¢5 months), providing post
18-month data for 804 (96¢6%) participants, of whom 785 (94¢4%) had a minimum of 36-months follow-up.
There was no evidence of a between-group difference in the primary outcome during the extended follow-up
period (Hazard Ratio (HR) 1¢03; 95% CI: 0¢83, 1¢28; p-value=0¢78), consistent with our findings in the original
trial with 18 months follow-up (HR 1¢14, 95% CI 0¢87, 1¢49; p-value 0¢33). There was a reduced rate of self-
harm in older participants aged 1517 (HR 0¢7, 95% CI 0¢56, 0¢88), as compared with those aged 1114; and
significantly increased rates of self-harm in participants whose index episode combined self-injury and poi-
soning (HR 1¢8, 95% CI 1¢2, 2¢7). Two deaths were reported during the extended follow up period.
Interpretation: For adolescents referred to CAMHS after self-harm, having self-harmed at least once before, trial FT
confers no benefits over TAU in reducing subsequent hospitalisation for self-harm over 18months or 36months.
Funding: NIHR HTA Reference: 07/33/01
© 2019 Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license.
(http://creativecommons.org/licenses/by-nc-nd/4.0/)Keywords:
Self-harm
Family therapy
Long term follow up
RCTpen access article under the CC BY-NC-ND license. (http://creativecommons.org/licenses/by-nc-nd/4.0/)1. Introduction
Self-harm in adolescents is a global public health problem, with
perhaps 11% of adolescents self-reporting self-harm within the last
year in England [1,2] and suicide the second commonest cause of
Research in Context
Evidence before this study
We searched electronic databases from the first available year
to 31 March 2007 for randomised controlled trials of interven-
tions to address self-harm in people under the age of 18, where
the primary outcome was reduction in self-harm. We identified
one trial of a token allowing re-admission, which found no
effect and one trial of group therapy for adolescents but no
other studies in the appropriate age group with reduction in
repetition of self-harm as the primary outcome (subsequent
replication of the group therapy study did not find a positive
impact of group therapy). We identified two studies of family
interventions related to self-harm; a depression study report-
ing suicidal ideation as a secondary outcome; and a study of a
home-based intervention designed to improve family commu-
nication, powered to detect between-group differences in sui-
cidal ideation, not repeat self-harm.
Added value of this study
We found no evidence that for adolescents referred to CAMHS
after self-harm, having self-harmed at least once before, the tri-
al’s manualised systemic family therapy conferred any benefits
over TAU in reducing subsequent hospitalisation for self-harm
at 36 months post-randomisation nor throughout the extended
follow-up period. Self-harm continued from 1836 months at
much the same rate as from 0 18 months. Younger girls, those
with multiple past self-harm events, and those who combine
self-poisoning with self-injury are at greater risk of further self-
harm. Further attendances at hospital for any reason are an
indicator of risk.
Implications of all the available evidence
SHIFT family therapy confers no additional benefits over TAU in
reducing subsequent hospitalisation for self-harm. Young peo-
ple who self-harm form a heterogeneous group with self-harm
likely to be the final common pathway for a wide range of pre-
dicaments. Further research is needed to develop a more per-
sonalised approach and to identify which interventions are
most helpful for which young people. This study suggests that
lack of repetition by 18 months is not an indication of no fur-
ther risk of repetition and points to a number of factors that
predict further self-harm and risk.
2 D.J. Cottrell et al. / EClinicalMedicine 18 (2020) 100246death in 10 to 24-year olds, after road traffic accidents [3]. A single
effective intervention has not been identified [4,5], and our recent,
large randomised controlled trial showed no specific benefit for a
manualised form of family therapy (FT) when compared with treat-
ment as usual (TAU) over an 18 month follow up period, whilst pro-
viding suggestions that some sub-groups might do better (or worse)
with FT [6].
Trials of interventions for children’s mental health are often
criticised for short follow-up duration. Studies in the most recent sys-
tematic review of interventions for adolescent self-harm [5] reported
a mean of 10.1 months follow up (range 224 months), with only
three studies reporting follow up beyond 12 months.
2. Methods
This paper presents the results of an extended follow up (to at
least 36 months post-randomisation) of the primary outcome and
other hospital related outcomes in the Self-Harm Intervention: Fam-
ily Therapy (SHIFT) trial. Detailed trial methods and results at 18months, have already been reported [6,7]. We present a brief sum-
mary of methods from the original trial, followed by a detailed
description of methods for the extended follow-up.
2.1. Brief summary of original trial methods
2.1.1. Design
A UK pragmatic, multi-centre individually-randomised, controlled
trial of FT compared with TAU.
2.1.2. Participants
Eligible adolescents 1117, living with a primary caregiver, had
self-harmed at least twice and were referred to CAMHS following
self-harm (index episode). In common with UK, European and Aus-
tralasian practice, we defined self-harm as any form of intentional
non-fatal self-poisoning or self-injury (including cutting, taking
excess medication, hanging, self-strangulation, jumping from height,
running into traffic), regardless of suicidal intent; this includes US
definitions of non-suicidal self-injury (NSSI) and suicidal behaviour.
2.1.3. Setting
Within 40 English National Health Service (NHS) CAMHS in 15
NHS Trusts across Greater Manchester, London and Yorkshire, young
people were screened by a CAMHS clinician following the index self-
harm episode. Those eligible and consenting to researcher contact
were visited at home by a researcher who discussed the trial,
obtained written consent for participation and conducted baseline
assessments.
2.1.4. Ethical approval
Approved by the UK NHS National Research Ethics Service in April
2009 (Reference: 09/H1307/20).
2.1.5. Randomisation and masking
Following consent and baseline assessment, 832 participants were
randomised sequentially to receive FT or TAU (1:1), via a computer-
generated minimisation programme incorporating a random ele-
ment, stratified by CAMHS, gender, age (1114 and 1517 based on
evidence that under 14 s might have lower intent and lower rates of
longer-term suicide [8]), living arrangements, previous self-harm
episodes, and index episode type. Family therapists working across
multiple services were also randomly allocated to FT participants.
Participants and therapists were aware of treatment allocation,
researchers were blinded.
2.1.6. Interventions
6-8 sessions of manualised and supervised FT [9] delivered by
experienced, qualified family therapists or for TAU, the care offered
to young people by local CAMHS teams. This was unrestricted and
expected to be diverse. Further information about SHIFT FT, TAU,
adherence and fidelity is reported elsewhere [6,10].
2.1.7. Outcomes
Primary outcome: Repetition of self-harm leading to hospital
attendance within 18 months post-randomisation. Secondary out-
comes included a range of clinical and economic outcomes at 12 and
18 months.
2.1.8. Assessment and data collection
Researcher administered and self-reported young person and
caregiver questionnaires at baseline, 12 and 18 months post-random-
isation; data from treating CAMHS clinicians, family therapists, and
local Research Networks. Hospital attendance data (primary out-
come) were obtained from Accident and Emergency (A&E) and in-
patient Hospital Episode Statistics (HES) datasets from NHS Digital
(https://digital.nhs.uk) up to January 2015, augmented by directed
D.J. Cottrell et al. / EClinicalMedicine 18 (2020) 100246 3hospital record searches, undertaken by blinded researchers until the
end of the 18-month follow-up period in June 2015 [11].
Link to published protocol for main trial: http://www.trialsjournal.
com/content/16/1/501
Trial registration: 26 January 2009. http://www.controlled-trials.
com/ISRCTN597931502.2. Extended follow-up methods2.2.1. Design
Additional data supplemented 18 month follow up. Extended fol-
low up to a minimum 36 months post-randomisation, of SHIFT par-
ticipants.2.2.2. Participants
Those in the original study unless consent for further data collec-
tion had been withdrawn.2.2.3. Ethical approval
In addition to the original approval, all participants who had not
already withdrawn were contacted via a newsletter and given an
option to withdraw from further follow up.2.2.4. Outcomes
Repetition of self-harm leading to hospital attendance (original
primary outcome); characteristics of further episodes of self-harm
leading to hospital attendance; all-cause morbidity and mortality; all
measured over the extended follow-up period.
Health economic methods and results will be published separately.2.2.5. Assessment and data collection
Three years after the last participant was recruited to the trial,
identifiers were sent to NHS Digital (https://digital.nhs.uk) for linkage
to A&E and in-patient HES datasets, providing follow-up data to Feb-
ruary 2017. ONS mortality data and adult mental health data were
also obtained, however, at the time of data collection an England
wide CAMHS data reporting system had not been agreed, and so data
on attendances to child and adolescent facilities were not available.
Identifiers were not sent for participants with original or subsequent
withdrawal from further clinical data collection, lack of original con-
sent for linkage, or where the newsletter alerting participants of
long-term follow-up could not be delivered to a current address
(address unknown or returned to sender). Where it was not possible
to obtain further HES data, participants’ post-18-month HES data
received within the original trial (to January 2015) were included.
As with the original trial, HES episode data were processed to
derive complete hospital attendances and classified as self-harm
related, possibly self-harm related, and not self-harm related [11].
Minor changes to the classification algorithm followed the original
trial (Supplementary Table 1). To maximise the chance of identifying
self-harm attendances given limited research resources and time,
unclassified attendances were prioritised, identifying those probably
self-harm related (Supplementary Table 2).
Directed hospital record searches of unclassified attendances
(including low priority attendances where time constraints allowed)
were undertaken by blinded researchers between July 2017 January
2018 [11]. to supplement routine HES data downloaded from NHS
Digital. Limited resources restricted our search and so we obtained
approval for researcher follow up in the 34 hospital providers identi-
fied where participants were most likely to attend (based on original
trial data and proximity to recruitment site). These researchers were
not involved in the original study, and had no knowledge of treat-
ment allocation.2.3. Statistical analysis
Analyses were conducted using SAS version 9.4, in the intention-
to-treat population and all statistical testing used two-sided 5% sig-
nificance levels.
We used Cox’s Proportional Hazards Model accounting for covari-
ates (minimisation factors sex, age (11-14 vs 15-17), two vs three or
more previous self-harm episodes, and index episode type; and NHS
Trust) to test for differences in longer-term repetition rates. Hazard
ratios; 95% confidence intervals (CIs) and KaplanMeier curves
showing time to self-harm for each group and estimates of repetition
rate are presented. Participants without an event were censored at
the time last known to be event free. A sensitivity analysis examined
the impact of unclassified hospital attendances. Moderators of treat-
ment effect, caregiver-reported affective involvement and young per-
son-reported unemotional traits, detected in the original 18 month
analysis [6], were re-assessed via interaction effects in the primary
endpoint analysis.
To analyse all hospital attendances due to self-harm, we conducted
a recurrent events analysis using the Andersen-Gill counting process
model [12] with robust sandwich variance estimator, and stratified
models for restricted gap-time and total time proposed by Prentice et
al. [13]. Each model provides common regression coefficient(s) across
recurrent events resulting in the marginal means model.
We present between-group differences in all-cause morbidity and
mortality, with morbidity measured through hospital attendances for
reasons other than self-harm (including unclassified attendances).
We explored the association between hospital attendances for rea-
sons other than self-harm, and for reasons related to self-harm, using
the Cochran-Mantel-Haenszel statistics [14] to estimate the common
odds ratio across treatment arm. Hospital admissions are investigated
through ICD-10 diagnosis codes (International Classification of Dis-
eases 10 [15]), and adversity-related admissions identified and
reported according to the methods of Herbert et al. [16,17].
2.3.1. Sample size
The original trial sample size of 832 (416 per group) provided 90%
power to detect a 35% relative reduction in 18-month repetition rates
between TAU (29%) and FT (18¢8%), using a 5% significance level log-
rank test for equality of survival curves, assuming 10% loss to follow-
up by 18 months for the primary outcome (repetition of self-harm
resulting in hospital attendance). The trial recruited to target; only 21
(2¢5%) withdrew from the primary outcome follow-up at 18 months.
3. Results
3.1. Follow-up
Additional data supplemented 18 month follow up for 804 (96¢6%)
participants; 785 (94¢4%) participants were followed up to a mini-
mum 36 months. Median overall length of follow up was 55¢4
months (range 0 - 82¢5, IQR 46¢7-66¢7, n = 832) (Fig. 1, Supplemen-
tary Figure 1). Follow up duration remained similar across trial arms,
and according to whether a primary outcome event was reported or
not (Supplementary Table 3).
3.2. Reported attendances
A total of 4359 previously unreported HES episodes were
retrieved and linked resulting in 3479 unique complete hospital
attendances (seven previously reported via researcher only). Of these,
333 (9¢6%) were classified as self-harm, 1600 (46¢0%) non self-harm,
and 1546 (44¢4%) were unclassified (Supplementary Figure 2).
Including 89 unclassified attendances remaining from the original
18-month follow-up, a total of 1635 unclassified attendances
required targeted researcher follow up; 408 (25¢0%) high and 1227
Original trial
Recruitment: N=832
April 2010 - Dec 2013
Identifiers not sent for linkage: 61 (7.3%)
- 2     No original consent for HES data
- 21 Original withdrawal
- 1     Withdrawal following newsletter
- 37   Could not send newsletter: address bounced/not current
Identifiers sent to NHS Digital for linkage: 
771 (92.7%)
Withdrawal from further 
clinical data collection: 21 
18 month Hospital follow-up
795 (95.6%) Complete 18m follow-up
33 (4.0%) Hospital follow-up <18m
4 (0.5%) No hospital follow up 
Original HES data to end Jan 2015. Final researcher 18 month follow up: June 2015.
Overall length of follow-up (N=832): mean 17.7 (SD 1.77), median 18, range 0-18 months.
Extended follow-up
Participant newsletter sent to all participants without 
withdrawal from further clinical data collection Sept 2016
Extended follow-up includes:
Additional >18m Hospital data (HES) for 804 (96.6%) participants (785 (94.4%) with ≥36 months follow up).
Overall length of follow-up (N=832): mean 55.1 (SD 14.36), median 55.4, range 0-82.5 months.
Researcher follow-up of unclassified hospital attendances
During July 2017 - Jan 2018
HES linkage: 766 (99.4% linkage rate) 
HES data received May 2017, data to Feb 2017
Identifiers not matched 
to HES: 5 (0.6%)
Post 18m HES data received during 
original trial follow-up*: 38 (4.6%)
(HES data to Jan 2015)
Fig. 1. Flow diagram and timing of participants’ original and extended follow-up.
*Note post 18 m HES data was included for these participants based on post 18 m HES data obtained during the original trial follow-up period. This data was not included in the
original 18-month analysis.
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103 different providers, of which 1284 (78¢5%) took place in 34 pro-
viders with approval for researcher follow up. Of these 1284 attend-
ances, 976 were followed up by the researcher, who contacted 271/
318 (85¢2%) high priority, and 705/966 (73¢0%) low priority attendan-
ces. Of those followed up 99/271 (36¢5%) high priority and 91/705
(12¢9%) low priority were found to be self-harm related.
Over the entire follow-up period (including original 18-month fol-
low up), 4985 attendances were reported, compared to 1513 in the
original 18-month follow-up: 927 (18¢6%) vs 404 (26¢7%) due to self-harm, 3383 (67¢9%) vs 1011 (66¢8%) not due to self-harm, and 675
(13¢5%) vs 98 (6¢5%) unclassified respectively.3.3. Repetition of self-harm leading to hospital attendance (original
primary outcome)
Over the entire follow-up period, a total 916 hospital attendances
(excluding 11 minor injury or walk-in centre attendances) following
self-harm were reported in 334 (40¢1%) of 832 young people; 427
Table 1
Details of self-harm events.
Family therapy N Treatment as usual N Total N
Number of participants 415 417 832
N participants with one or more self-harm event 168 (40.5%) 166 (39.8%) 334 (40.1%)
Estimated self-harm repetition rate (Kaplan Meier estimate, 95% CI)
18 months 28.9% (24.5%, 33.3%) 25.2% (21.0%, 29.4%) 27.1% (24.0%, 30.1%)
36 months 36.5% (31.8%, 41.2%) 35.4% (30.8%, 40.1%) 36.0% (32.7%, 39.3%)
N events per participant
Mean (SD) 1.0 (2.19) 1.2 (3.22) 1.1 (2.76)
Median (range) 0.0 (0, 22) 0.0 (0, 39) 0.0 (0, 39)
IQR (0, 1) (0, 1) (0, 1)
N events per participant
0 247 (59.5%) 251 (60.2%) 498 (59.9%)
1 75 (18.1%) 75 (18.0%) 150 (18.0%)
2-3 66 (15.9%) 53 (12.7%) 119 (14.3%)
4-5 14 (3.4%) 23 (5.5%) 37 (4.4%)
6+ 13 (3.1%) 15 (3.6%) 28 (3.4%)
Type of self-harm per participant a (not mutually exclusive)
Self-injury 72 (17.3%) 75 (18.0%) 147 (17.7%)
Self-poisoning 122 (29.4%) 124 (29.7%) 246 (29.6%)
Self-injury and poisoning 18 (4.3%) 22 (5.3%) 40 (4.8%)
Other (Threats/Thoughts/Risk) 30 (7.2%) 28 (6.7%) 58 (7.0%)
Missing 13 (3.1%) 15 (3.6%) 28 (3.4%)
No self-harm event 247 (59.5%) 251 (60.2%) 498 (59.9%)
Total number of events 427 489 916
Type of self-harm
Self-injury 128 (30.0%) 160 (32.7%) 288 (31.4%)
Self-poisoning 216 (50.6%) 238 (48.7%) 454 (49.6%)
Self-injury and poisoning 20 (4.7%) 27 (5.5%) 47 (5.1%)
Other (Threats/Thoughts/Risk) 42 (9.8%) 44 (9.0%) 86 (9.4%)
Missing 21 (4.9%) 20 (4.1%) 41 (4.5%)
Outcome of self-harm eventsb
Discharged from A&E 174 (40.7%) 216 (44.2%) 390 (42.6%)
Admitted to hospital ward 253 (59.3%) 273 (55.8%) 526 (57.4%)
Admission involves a psychiatric inpatient stay?
Yesc 16 (6.3%) 23 (8.4%) 39 (7.4%)
No 237 (93.7%) 250 (91.6%) 487 (92.6%)
Total Admissions 253 (100%) 273 (100%) 526 (100%)
a Of 184 participants with more than one self-harm event, 98 (53.3%) used multiple methods, 86 (46.7%) used a single method (excluding threats
as an alternative method).
b The 390 events discharged from A&E and the 526 admission events were in 187 (22.5%) and 249 (29.9%) participants respectively.
c The 39 psychiatric admissions were in 23 (2.8%) participants.
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(39¢8%) of 417 in the TAU group (Table 1).
Self-harm repetition can be seen to continue at a similar rate
beyond the original 18-month follow-up period (Fig. 2), with Kaplan
Meier estimated self-harm rates (Table 1) of 27¢1% (95% CI: 24¢0%,
30¢1%) at 18 months, increasing to 36¢0% (95% CI: 32¢7%, 39¢3%) at 36
months post-randomisation. The Kaplan Meier curves for FT and TAU
can be seen to be at their most divergent around 18 months post-ran-
domisation, the timing of original primary analysis, before converg-
ing from 36 months.
Consistent with the original 18-month follow-up, whilst the esti-
mated HR (1¢03, 95% CI: 0¢83, 1¢28, p-value=0¢78) represents a mar-
ginally increased rate of self-harm in FT compared to TAU, there is no
evidence to suggest a statistically or clinically significant difference in
self-harm repetition rates between treatment groups over the dura-
tion of the extended follow-up (Table 2).
Repeated self-harm was less common in participants who were
15 years or older and more common in participants with an index
episode combining self-injury and poisoning. A significant effect on
the risk of self-harm, irrespective of treatment arm, was detected for
the NHS Trust where the patient was located (p = 0¢0078). Whilst
weak evidence of an increased rate of self-harm in females was
detected in the original 18-month follow-up, this effect was reduced
within the extended follow up. Further investigation detected a sig-
nificant interaction between age and gender, with younger females
more likely to repeat self-harm (p = 0¢022, Supplementary Figure 3).
Sensitivity analyses yielded similar results (Supplementary text andSupplementary Figure 4) (i.e. using an alternative modelling strategy
for centre investigating the impact of remaining unclassified attend-
ances).
3.4. Moderation
Our extended follow-up found a similar trend for the moderating
effect of caregiver-reported affective involvement, and for young per-
son-reported unemotional traits on treatment effect, as detected at
18 months. Affective involvement problems increased the risk of self-
harm to a greater degree in TAU (HR 1¢5, 95% CI 1¢102¢03) than in
FT (HR 1.06, 95% CI 0¢751¢49). As difficulty in talking about feelings
increased, the risk of self-harm decreased in TAU (HR 0¢93, 95% CI
0¢880¢99) and increased in FT (HR 1¢05, 95% CI I 0¢981¢12). How-
ever there was no longer evidence of a statistically significant treat-
ment interaction for either moderator (p = 0.1361, p = 0.2731).
3.5. Characteristics of further episodes of self-harm leading to hospital
attendance
Time to recurrent self-harm events (up to the fourth event per
participant) is shown in Kaplan-Meier plots in Fig. 3, from (a) ran-
domisation, and (b) the previous self-harm event. The at-risk popula-
tion comprises all participants for the first event, and participants
with a preceding event for subsequent events, i.e. only those with a
first event are at risk of a second event. Having a first event substan-
tially increased the risk of having a second, with subsequent events
Fig. 2. Kaplan-Meier plot of time to self-harm by Randomised Treatment group with 95% CIs.
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each event (Fig. 3b). Similar findings were observed across trial arms
(not presented).
Recurrent event analysis (Supplementary Table 4) over the
extended follow up of the participants found no evidence to suggest
a statistically significant difference in the rate of recurrent events
between the arms (HR 0¢86, 95% CI: 0¢63, 1.19, p-value=0¢3746). In
contrast to the analysis of the first event in the extended follow-up,
the number of previous self-harm episodes was highly significant
with an increased rate of recurrent self-harm in those with three orTable 2
Cox Proportional Hazards Model (adjusted for covariates) for time to first event.
Original 18-month follow-up
Hazard Ratio (95% CI) p-value Haz
Treatment: FT (vs. TAU) 1.14 (0.87, 1.49) 0.33 1.03
Gender: female (vs. male) 1.60 (0.98, 2.61) 0.059 1.22
11-14 years
15-17 years
Age group: 1517 (vs. 1114) 0.70 (0.53, 0.92) 0.011 0.7
Females
Males
Gender*Age: Female*15-17
Previous self-harm episodes:  3 (vs. 2) 1.22 (0.78, 1.92) 0.39 1.16
Type of index episode: 0.033
Combined (vs. Injury) 1.83 (1.14, 2.96) 1.80
Poisoning (vs. Injury) 1.03 (0.69, 1.54) 1.11
Referred via hospital: yes (vs. no) 1.31 (0.93, 1.86) 0.12 1.03
NHS Trust 0.094more self-harm episodes at baseline (HR 2¢05, 95% CI: 1¢35, 3¢12, p-
value=0¢0008) and there was a higher rate of self-harm in those
referred via hospital (HR 1¢64, 95% CI 1¢04, 2¢61, p-value=0¢0348).
3.6. All cause morbidity and mortality
Over the extended follow-up period, two participants were
reported to have died, between three and four years post randomisa-
tion. Both participants were allocated to FT; neither death was
related to self-harm.Full long-term follow-up
Primary analysis Exploratory analysis  Gender* Age interaction
ard Ratio (95% CI) p-value Hazard Ratio (95% CI) p-value
(0.83, 1.28) 0.78 1.03 (0.83, 1.28) 0.77
(0.86, 1.73) 0.25 0.028
1.76 (1.06, 2.91)
0.78 (0.48, 1.27)
(0.56, 0.88) 0.0019 0.28
0.64 (0.50, 0.81)
1.44 [0.74, 2.77)
0.022
(0.81, 1.66) 0.42 1.13 (0.79, 1.63) 0.495
0.015 0.015
(1.20, 2.70) 1.81 (1.21, 2.71)
(0.79, 1.54) 1.13 (0.81, 1.59)
(0.77, 1.37) 0.86 1.00 (0.75, 1.34) 0.9975
0.0078 0.0095
Fig. 3. KaplanMeier plot of time to recurrent self-harm events (up to 4 events) (a) from randomisation, and (b) between self-harm events.
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harm (including unclassified attendances), were reported over the
extended follow-up period, for 333 (80¢2%) participants in the FT arm
and 343 (82¢3%) in TAU; with a median of three attendances per par-
ticipant in both arms, and a mean of 4¢9 (SD 6¢58). A&E attendances
resulting in discharge were more common than admissions: 627
(75¢4%) participants attended A&E and were discharged. 416 (50%)participants had a hospital admission, with a mean of 3¢2 A&E attend-
ances and 1¢6 admissions per participant (Supplementary Table 5).
Exploratory analysis found that participants with a primary out-
come self-harm event during follow-up were more likely to attend
hospital for other non-self-harm reasons (Odds Ratio: 2¢32, 95% CI
1¢57-3¢44, p-value < 0¢001) and more often than those without a pri-
mary outcome event. This was consistent for both A&E attendances
8 D.J. Cottrell et al. / EClinicalMedicine 18 (2020) 100246and hospital admissions, and across trial arms, with no evidence of a
statistically significant difference between trial arms.
3.7. Non-self-harm hospital admissions
Similar admission rates according to ICD-10 diagnosis classifica-
tion were observed across trial arms (Supplementary Tables 6 and 7).
Rates of admission were higher across almost all ICD-10 classifica-
tions in participants with a primary outcome self-harm hospital atten-
dance; in particular for mental and behavioural disorders (ICD-10 F01-
F99), and symptoms, signs, abnormal clinical & lab findings (ICD-10
R00-R99). Considering all mental health related ICD-10 codes, diagno-
sis codes for A&E attendances leading to admission, and researcher-
reported details, 486 (35¢9%) admissions in 239 (28¢7%) participants
contained a mental health related diagnosis. In participants with a pri-
mary outcome event this included 335 (48%) admissions in 143
(42¢8%) participants; compared to 151 (23%) admissions in 96 (19¢3%)
participants without a primary outcome event. Excluding psychoactive
substance use, 337 (24¢9%) admissions in 172 (20¢7%) participants
received a mental health related diagnosis (Table 3).
3.8. Adversity related hospital admissions
Approximately 260 (31¢3%) participants had one or more emer-
gency admission for adversity related injury for self-harm, violence,
drug or alcohol abuse (girls 28¢9%, boys 31¢9%), accounting for 88% of
all emergency admissions for injury (girls 89¢5%, boys 76¢2%), and
28¢3% of all admissions (girls 27¢6%, boys 37¢5%) (Supplementary
Table 8). This compares to approximately 4¢3% (n = 141,248) of ado-
lescents in the general population (n = 3,254,046) with one or more
emergency admissions for adversity related injury (girls 4¢6%, boys
4¢1%), accounting for 50% of all emergency admissions for injury in
girls and 29¢1% in boys [16,17].
4. Discussion
This trial tested the impact of a specifically adapted and manual-
ised family therapy intervention for self-harming adolescents. In
young people who had self-harmed more than once and had done so
recently, at 36 months follow up, and throughout the complete
extended follow-up period we found no clinical benefits for FT over
TAU in reducing hospital attendance due to subsequent repetition of
self-harm. At 18 months, repetition curves were diverging but our
extended follow up shows that from month 24 repetition rates begin
to converge again, with no difference from month 42.
However, a number of important clinical implications arise from
the findings. Firstly, rates of self-harm continued from 18 to 36
months, at much the same rate as they did from 0 to 18 months,
although the risk of repetition is probably highest in the first 12
months. Lack of repetition at 18 months should not be seen as an
indication of no further risk of repetition.Table 3
Non self-harm hospital admissions for mental health related reasons (excluding self-harm ev
Family therapy
Primary outcome self-harm event? P
Mental Health related admission* Yes No Total Y
N participants 168 247 415 1
Yes (Including substance use F10-F19**) 77 (45.8%) 40 (16.2%) 117 (28.2%) 6
Yes (Excluding substance use F10-F19) 64 (38.1%) 24 (9.7%) 88 (21.2%) 5
N admissions 382 283 665 3
Yes (Including substance use F10-F19) 164 (42.9%) 70 (24.7%) 234 (35.2%) 1
Yes (Excluding substance use F10-F19) 114 (29.8%) 39 (13.8%) 153 (23.0%) 1
* Excludes admissions for self-harm (primary outcome events).
** F10-F19 refer to the disease classification codes in ICD-10 [15].Secondly, across the whole trial cohort we found a reduced rate of
repeated self-harm in older participants aged 15-17 compared to
those aged 11  14, suggesting a reduction in self-harm repetition as
adolescence proceeds. This is consistent with other findings, with
similar results in the ASSIST trial [18].
Thirdly we found two important indicators of repetition risk with
a significantly increased rate of self-harm in participants whose index
episode combined self-injury and poisoning compared to those with
self-injury only, and a significant interaction between age and gen-
der, with younger females more likely to repeat self-harm  as has
been shown in other studies [2,19].
Fourthly, analysis of all self-harm episodes leading to hospital
attendance showed that having a second self-harm event (bearing in
mind this group had already self-harmed at least twice prior to ran-
domisation) substantially increased the risk of having a third, and the
time to subsequent events decreased with each event. In contrast to
the 18-month primary analysis of the first event, there was a higher
rate of recurrent self-harm in those with three or more self-harm epi-
sodes at baseline compared to those with two.
There was a significant difference in the rate of repeat self-harm
across study centres, with participants recruited from some centres
significantly less likely to repeat self-harm and more likely in others.
This finding was irrespective of treatment arm and could have been
be due to a variety of reasons  random variation, differences in pop-
ulation, differences in type and quality of therapy offered, however,
with the data available it is not possible to draw firm conclusions.
Finally, participants with a primary outcome self-harm event dur-
ing follow up were more likely to attend hospital for reasons other
than self-harm and more often than those without a primary out-
come event and were more likely to have a mental and behavioural
disorder diagnostic code linked with their admission. Herbert et al.
[17] reported that the risk of death from suicide or from drug or alco-
hol related causes was significantly higher in young people who had
an emergency hospital admission following adversity related injury.
In the present study, a far higher proportion of participants were
admitted following adversity related injury than in the national
cohort of Herbert et al., suggesting an even higher risk of death from
suicide or from a drug or alcohol related cause.
This is the largest trial of a self-harm intervention and one of the
largest ever conducted in CAMHS for any condition. The use of hospi-
tal episode statistics and ONSmortality data demonstrates their feasi-
bility and potential as objective outcome measures in studies of this
type and led to very high ascertainment (additional primary outcome
data after 18 months on 804/832 [96¢6%] participants; linkage rate of
766/771 [99¢4%] participants further submitted to NHS Digital). Fol-
low-up extending up to 82¢5 months post-randomisation (median of
55¢4 months) and a similar duration of follow-up across both trial
arms are further strengths.
We have previously reported that the trial sample presented with
levels of difficulty at least as severe as the average UK CAMHS referral
and that TAUwas broadly comparable to CAMHS practice in the UK [6].ents) by trial arm and primary outcome event status during overall follow-up.
Treatment as usual Total
rimary outcome self-harm event? Primary outcome self-harm event?
es No Total Yes No Total
66 251 417 334 498 832
6 (39.8%) 56 (22.3%) 122 (29.3%) 143 (42.8%) 96 (19.3%) 239 (28.7%)
3 (31.9%) 31 (12.4%) 84 (20.1%) 117 (35.0%) 55 (11.0%) 172 (20.7%)
16 374 690 698 657 1355
71 (54.1%) 81 (21.7%) 252 (36.5%) 335 (48.0%) 151 (23.0%) 486 (35.9%)
35 (42.7%) 49 (13.1%) 184 (26.7%) 249 (35.7%) 88 (13.4%) 337 (24.9%)
D.J. Cottrell et al. / EClinicalMedicine 18 (2020) 100246 9Although the routine data we collected indicated that only 20¢7% of
participants (excluding those with a psychoactive substance use diag-
nosis) received a mental health related diagnosis, this may reflect the
use of data which is derived from the involvement of non-psychiatric
staff in acute hospitals whomay be reluctant to commit to formal diag-
noses. It should be noted that at baseline our sample had relatively
high rates of emotional and behavioural problems generally (66%
scored high or very high on the Strengths and Difficulties Question-
naire) and for depression in particular (66% scored moderately
depressed or above on the Children’s Depression Rating Scale) [6].
Limitations, in addition to those cited at 18 month follow up [6],
include the differential lengths of follow-up for participants for
whom the acquisition of further HES data was not possible, remain-
ing unclassified attendances, and the resource and length of time
required to achieve approval and to conduct researcher follow-up of
unclassified attendances. A further limitation may have been an inad-
equate ‘dose’ of SHIFT FT. Treatment length was informed by the typi-
cal length of treatment offered in UK CAMH services so as to ensure
broadly equal amounts of contact in this pragmatic trial. This issue is
addressed in more detail in the original trial publication [6].
Although conclusions about the primary outcome with respect to
treatment differences are unchanged, this extended follow-up con-
firmed a number of factors that predict repetition in this at-risk clini-
cal group. Clinicians should exercise more caution with younger girls,
those with multiple past self-harm events, and those who combine
self-poisoning with self-injury. In a young person who has self-
harmed, attendance at hospital for any reason may be an indicator of
risk but those who re-present with an adversity-related injury may
be at particular risk.
The Multicentre Study of Self-harm in England investigated mor-
tality following self-harm [20] collected data on all patients aged
18 years and under who presented with self-harm to general hospital
emergency departments in Oxford (one), Manchester (three) and
Derby (two) for the 8-year period 1 January 2000 to 31 December
2007. As in the present study, self-harm was defined as intentional
self-poisoning or self-injury, irrespective of type of motivation
including degree of suicidal intent. No data are available about inter-
ventions offered to this cohort, although it is unlikely that all were
offered treatment. Follow up until 31 December 2010 for 5133 of the
5205 (98¢6%), using national mortality registers (median follow-up
period, 6 years), showed that overall, 51 (1%) had died by the end of
the follow-up period, nearly half by suicide or probable suicide
(undetermined cause) (N = 25, 49¢0%), a quarter (25¢5%) with an acci-
dental verdict, and a quarter (25¢5%) due to other causes. In our study,
over a similar follow up period (median 55 months), but with a more
at-risk group (as all SHIFT participants had self-harmed at least twice
before randomisation), two (0¢2%) deaths were reported. Numbers
are too small to draw firm conclusions, but this finding raises the pos-
sibility that treatment of any sort may reduce subsequent mortality.
We continue to argue that future research related to adolescent
self-harm needs to explore the characteristics of specific sub-groups
within the self-harming population. As it is still not clear yet what
works for whom in this population, the adoption of newer methods
such as micro- trials may help in the optimisation of treatments
offered [21] although such methods may not be able to deal with the
heterogeneity in the target population. Additional options such as
the modelling of large datasets that include therapy data might also
be considered. The findings of this study also make the case that
intervention trials in child and adolescent mental health need longer
follow-up periods to inform evidence-based services.
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